Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henry Bussey

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 29, 2002
Traditional anticoagulant therapy: why abandon half a century of success?Henry Bussey
Annals of Internal Medicine|February 17, 2010
The net clinical benefit of warfarin anticoagulation in atrial fibrillationHenry Bussey
Pharmacotherapy|September 1, 2004
Heparin overview and issuesHenry Bussey, John L Francis,
Chest|September 24, 2004
The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyJack Ansell, Jack Hirsh, Leon Poller, et al.
Journal of the American Medical Directors Association|March 2, 2010
Thrombotic risk and immobility in residents of long-term care facilitiesBarbara J Zarowitz, Eric Tangalos, Allen Lefkovitz, et al.
American Journal of Hematology|July 18, 2009
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: PreventionDavid Garcia, Walter Ageno, Henry Bussey, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 29, 2002
Traditional anticoagulant therapy: why abandon half a century of success?Henry Bussey
Annals of Internal Medicine|February 17, 2010
The net clinical benefit of warfarin anticoagulation in atrial fibrillationHenry Bussey
Pharmacotherapy|September 1, 2004
Heparin overview and issuesHenry Bussey, John L Francis,
Chest|September 24, 2004
The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyJack Ansell, Jack Hirsh, Leon Poller, et al.
Journal of the American Medical Directors Association|March 2, 2010
Thrombotic risk and immobility in residents of long-term care facilitiesBarbara J Zarowitz, Eric Tangalos, Allen Lefkovitz, et al.
American Journal of Hematology|July 18, 2009
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: PreventionDavid Garcia, Walter Ageno, Henry Bussey, et al.
Pageof 1